VIR

Vir Biotechnology, Inc.

• Simply Wall St·11h ago

  Vir Biotechnology (VIR) As Gilead Deal Puts Its Valuation Narrative Back In Focus

• Dow Jones·4d ago

  Press Release: Vir Biotechnology to Host Conference Call for Third Quarter 2026 Financial Results

• Simply Wall St·5d ago

  Gilead Cancer Drug Deal Might Change The Case For Investing In Vir Biotechnology (VIR)

• TipRanks·6d ago

  Analysts’ Top Healthcare Picks: Eli Lilly & Co (LLY), Vir Biotechnology (VIR)

• Simply Wall St·10/18 06:31

  Vir Biotechnology (VIR) Could Be 54% Undervalued After Gilead Collaboration

• Benzinga·10/14 16:58

  Vir Biotechnology, Gilead Strike Deal for Novel Tumor Treatments

• NASDAQ·10/14 15:06

  Vir Biotechnology Partners With Gilead On Next-Generation Cancer Immunotherapy Programs

• Dow Jones·10/14 13:44

  Vir Biotechnology Shares Jump on Gilead Cancer Collaboration

• Seeking Alpha·10/14 13:09

  Vir jumps on Gilead licensing deal worth up to $1.9B for cancer drugs

• TipRanks·10/14 12:59

  Vir Biotechnology seals major oncology alliance with Gilead

• TipRanks·10/14 12:41

  Vir Biotechnology enters collaboration, license agreement with Gilead

• Benzinga·10/14 12:40

  Vir Biotechnology Signs Up To $1.875B Gilead Deal For 3 Cancer Drug Candidates; Gilead To Pay $65M Cash Upfront And Buy 1,765,486 Shares At $14.16 Each, For A Total Of $25M, Plus Up To $1.785B In Milestones And Royalties

• Benzinga·10/14 12:34

  Vir Biotechnology Announces Collaboration, License Agreement With Gilead To Discover, Engineer Three PRO-XTEN Dual-Masked T-Cell Engager Development Candidates Targeting Selected Solid Tumor-Associated Antigens

• Simply Wall St·10/13 10:25

  Is FDA Fast Track Status Altering The Investment Case For Vir Biotechnology (VIR)?

• Simply Wall St·10/10 16:42

  Is Vir Biotechnology (VIR) Cheap On Fast Track News And SOLSTICE Data Hopes?